Biora Therapeutics, Inc. Earnings Per Share (Diluted)
Biora Therapeutics, Inc. reported Earnings Per Share (Diluted) of -$5.04 per share for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2024-11-14
- Biora Therapeutics, Inc. earnings per share, diluted for the quarter ending 2024-09-30 was -$5.04.
- Biora Therapeutics, Inc. earnings per share, diluted for the quarter ending 2024-06-30 was -$0.04.
- Biora Therapeutics, Inc. earnings per share, diluted for the quarter ending 2024-03-31 was -$0.14.
- Biora Therapeutics, Inc. earnings per share, diluted for the quarter ending 2023-12-31 was -$0.26.
- Biora Therapeutics, Inc. earnings per share, diluted for fiscal 2023 was -$7.87.
- Biora Therapeutics, Inc. earnings per share, diluted for fiscal 2022 was -$5.00.
- Biora Therapeutics, Inc. earnings per share, diluted for fiscal 2021 was -$64.33.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 3 month as first filed | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 9 month as first filed | Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|---|---|
| 2024-09-30 | -$5.04 10-Q · filed 2024-11-14 | -$0.31 derived: net income ÷ weighted average shares · filed 2024-11-14 | -$5.06 10-Q · filed 2024-11-14 | -$0.76 derived: net income ÷ weighted average shares · filed 2024-11-14 | ||
| 2024-06-30 | -$0.04 10-Q · filed 2024-08-12 | -$0.06 10-Q · filed 2024-08-12 | -$0.24 derived: net income ÷ weighted average shares · filed 2024-11-14 | -$2.11 derived: net income ÷ weighted average shares · filed 2024-11-14 | ||
| 2024-03-31 | -$0.14 10-Q · filed 2024-05-15 | -$0.44 derived: net income ÷ weighted average shares · filed 2024-11-14 | -$3.10 derived: net income ÷ weighted average shares · filed 2024-11-14 | -$4.34 derived: net income ÷ weighted average shares · filed 2024-11-14 | ||
| 2023-12-31 | -$0.26 derived: net income ÷ weighted average shares · filed 2024-04-01 | -$2.92 derived: net income ÷ weighted average shares · filed 2024-11-14 | -$4.39 derived: net income ÷ weighted average shares · filed 2024-11-14 | -$7.87 10-K · filed 2024-04-01 | ||
| 2023-09-30 | -$48.89 10-Q · filed 2024-11-14 | -$4.89 10-Q · filed 2023-11-13 | -$13.38 derived: net income ÷ weighted average shares · filed 2024-11-14 | -$85.41 10-Q · filed 2024-11-14 | -$8.54 10-Q · filed 2023-11-13 | -$14.85 derived: net income ÷ weighted average shares · filed 2024-11-14 |
| 2023-06-30 | -$1.47 10-Q · filed 2024-08-12 | -$3.01 10-Q · filed 2024-08-12 | -$4.67 derived: net income ÷ weighted average shares · filed 2024-11-14 | -$5.55 derived: net income ÷ weighted average shares · filed 2024-11-14 | ||
| 2023-03-31 | -$1.59 10-Q · filed 2024-05-15 | -$3.22 derived: net income ÷ weighted average shares · filed 2024-11-14 | -$4.06 derived: net income ÷ weighted average shares · filed 2024-11-14 | -$4.89 derived: net income ÷ weighted average shares · filed 2024-11-14 | ||
| 2022-12-31 | -$1.64 10-K · filed 2023-03-30 | -$2.38 derived: net income ÷ weighted average shares · filed 2024-04-01 | -$3.15 derived: net income ÷ weighted average shares · filed 2024-04-01 | -$5.00 10-K · filed 2024-04-01 | ||
| 2022-09-30 | -$0.68 10-Q · filed 2023-11-13 | -$0.03 10-Q · filed 2022-11-14 | -$1.43 derived: net income ÷ weighted average shares · filed 2023-11-13 | -$3.30 10-Q · filed 2023-11-13 | -$0.13 10-Q · filed 2022-11-14 | $2.60 derived: net income ÷ weighted average shares · filed 2023-11-13 |
| 2022-06-30 | -$0.75 10-Q · filed 2023-08-14 | -$2.63 10-Q · filed 2023-08-14 | $1.79 derived: net income ÷ weighted average shares · filed 2023-11-13 | $6.79 derived: net income ÷ weighted average shares · filed 2023-11-13 | ||
| 2022-03-31 | -$1.88 10-Q · filed 2023-05-15 | $1.09 derived: net income ÷ weighted average shares · filed 2023-11-13 | $4.55 derived: net income ÷ weighted average shares · filed 2023-11-13 | |||
| 2021-12-31 | -$13.98 10-K · filed 2023-03-30 | $2.56 derived: net income ÷ weighted average shares · filed 2023-03-30 | -$64.33 10-K · filed 2023-03-30 | |||
| 2021-09-30 | -$11.41 10-K · filed 2023-03-30 | -$0.46 10-Q · filed 2022-11-14 | -$2.13 10-Q · filed 2022-11-14 | |||
| 2021-06-30 | -$30.70 10-K · filed 2023-03-30 | |||||
| 2021-03-31 | -$14.03 10-K · filed 2023-03-30 |